Lebanon vs Saudi Arabia: Share of S. aureus infections resistant to methicillin
Lebanon
52.5%
in 2022
Saudi Arabia
52.0%
in 2022
Lebanon rank
10th
Saudi Arabia rank
11th
Share of S. aureus infections resistant to methicillin over time
- Lebanon
- Saudi Arabia
How they compare
Lebanon currently reports 52.5% against 52.0% in Saudi Arabia, a difference of 0.5%.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Saudi Arabia ahead.
Lebanon ranks 10th and Saudi Arabia ranks 11th of 45 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lebanon | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 17.8% | 42.8% | 25.1% | Saudi Arabia |
| 2020s | 41.6% | 67.5% | 25.9% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Lebanon or Saudi Arabia?
- Lebanon, at 52.5% against 52.0% in Saudi Arabia as of 2022.
- What is the difference in share of s. aureus infections resistant to methicillin between Lebanon and Saudi Arabia?
- 0.5%, with Lebanon ahead.
- How many years of comparable data are there for Lebanon and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Lebanon and Saudi Arabia rank globally for share of s. aureus infections resistant to methicillin?
- Lebanon ranks 10th and Saudi Arabia ranks 11th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).